Lv1
100 积分 2021-05-19 加入
AZD5305 More Tolerable than Earlier PARP Agents
1年前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
1年前
已完结
Glucose-Responsive Self-Rolling Antioxidant Hydrogel Actuators for a Cell Culture Platform
1年前
已完结